Metoclopramide Dosing and Safety in Pediatric Patients

Standard Dosing and Administration

• The American Academy of Pediatrics recommends a metoclopramide dose of 0.1 mg/kg per dose for children under 6 years, with a maximum frequency not to be combined with tramadol, and contraindicated if under 1 year old 1
• For chemotherapy-induced nausea and vomiting, a high-dose regimen of 1-2 mg/kg per dose IV is administered slowly over 15 minutes, given 30 minutes before chemotherapy 2

Critical Safety Considerations

• The primary concern with metoclopramide in children is the high incidence of extrapyramidal reactions (EPS), which occurs in pediatric patients, with key risk factors including higher doses, consecutive day dosing, and younger age 1
• If acute dystonic reactions occur, the American Academy of Pediatrics recommends immediately administering diphenhydramine 1-2 mg/kg (or 25-50 mg/dose) parenterally 3

Dosing Adjustments and Regulatory Restrictions

• The FDA recommends contraindication in children under 1 year of age, and use with caution in children under 5 years of age, with a duration not to exceed 5 days, and not to be combined with tramadol 1
• A rounding tolerance of 10% is considered acceptable by expert consensus, reflecting the balance between avoiding adverse effects and achieving practical dosing in real-world settings 4